spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Sigma 

 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2024
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Devices Diagnostics Product Launch
 HSMN NewsFeed - 7 Jun 2024
DePuy Synthes Receives 510(k) FDA Clearance of the VELYS(TM) Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
Devices Orthopaedic FDA
 HSMN NewsFeed - 16 Aug 2023
VintaBio Names Jennifer Kingsley Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2023
Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2023
Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
Diagnostics FDA
 HSMN NewsFeed - 16 Dec 2022
Curate Biosciences Announces David Backer as Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 21 Jul 2022
Molecular Testing Labs Announces Selection of Eric Strafel as New CEO
Diagnostics Personnel
 HSMN NewsFeed - 24 May 2022
Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Dec 2021
Merck Acquires Chord Therapeutics to Expand Neuroinflammatory Pipeline
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 14 Jun 2021
KT and NeuroSigma Announce Strategic Digital Health Partnership
Devices
 HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Mar 2021
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Mar 2021
Merck KGaA, Darmstadt, Germany, Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Dec 2020
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Sep 2020
Lilly Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2020
FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Mar 2020
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jan 2020
Insmed Appoints Sara Bonstein as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2019
Teijin and NeuroSigma Enter into Exclusive License Agreement
Devices Neurology Licensing
 HSMN NewsFeed - 25 Sep 2019
Launch of the Penlon Sigma EVA Vaporizer for Desflurane
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 11 Sep 2019
Merck KGaA, Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA(R) (gilteritinib)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2019
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Dec 2018
Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Dec 2018
EUSA Pharma Appoints Jeffrey S. Hackman as President US Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Aug 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2018
Cogmedix Welcomes David Fraser as New Senior Vice President of Operations
Devices Personnel
 HSMN NewsFeed - 6 Mar 2018
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 30 Oct 2017
UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD
Devices Neurology
 HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Sep 2017
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years with Maximum of Only 20 Days Oral Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 25 Aug 2017
European Commission Grants Approval for Mavenclad (Cladribine Tablets)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 8 Aug 2017
Millar, Inc. Appoints Linda Henley as Chief Financial Officer
Devices Cardiology Monitoring Personnel
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Jun 2017
Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Apr 2017
Penumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors
Devices Interventional Personnel
 HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 21 Mar 2017
Eyevensys Appoints Leading Life Sciences Executive and Ophthalmology Expert Dr. Garth Cumberlidge as Chairman
Biopharmaceuticals Devices Ophthalmology Personnel
 HSMN NewsFeed - 1 Mar 2017
Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2017
Sangamo Therapeutics Announces Chief Financial Officer Succession
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Jan 2017
Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership
Biopharmaceuticals
 HSMN NewsFeed - 30 Nov 2016
Novogene Completes USD $75 Million B Round Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Oct 2016
Rapid Micro Biosystems Announces New Vice President of Product Development
Devices Personnel
 HSMN NewsFeed - 20 Jun 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 2 Mar 2016
Merck KGaA, Darmstadt, Germany Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2015
Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Dec 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2015
NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD
Devices Neurology Regulatory
 HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2015
Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 21 Oct 2014
NeuroSigma Receives Notice of Allowance of U.S. Patent Application
Devices Neurology
 HSMN NewsFeed - 18 Sep 2014
NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Jul 2014
Advances in Trigeminal Nerve Stimulation Featured at European Congress on Epileptology in Stockholm, Sweden
Devices Neurology
 HSMN NewsFeed - 30 Jun 2014
Benvenue Medical Expands Senior Management Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 3 Jun 2014
Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 28 Mar 2014
NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives
Devices Neurology Personnel
 HSMN NewsFeed - 25 Feb 2014
David Hayes, Former Partner at O'Melveny & Myers LLP and Haynes and Boone LLP, Joins NeuroSigma As Chief Administrative Officer, General Counsel and Sr. Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 20 Feb 2014
Vascular Pathways Names Thomas Grifa as Vice-President Manufacturing
Devices Personnel
 HSMN NewsFeed - 11 Feb 2014
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
Devices Neurology Personnel
 HSMN NewsFeed - 27 Jan 2014
Former Allergan Marketing Executive Gregory F. Brooks Joins NeuroSigma As Senior VP and Chief Commercial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2013
Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Nov 2013
Camargo Pharmaceutical Services Names Jim Beach Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2013
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 14 Aug 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2013
Arrhythmia Research Technology, Inc. Announces New President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 4 Feb 2013
JenaValve Appoints John F. Migliazza, Chief Operating Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 8 Jan 2013
AtheroNova Names New Clinical Affairs Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 29 Oct 2012
Sigma-Tau Pharmaceuticals, Inc. Announces Appointment of New Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2012
Sigma-Tau Pharmaceuticals, Inc. Receives FDA Approval of CYSTARAN(TM) (Cysteamine Ophthalmic Solution) 0.44% for Treatment of Corneal Cystine Crystals in Cystinosis Patients
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 2 Jul 2012
NeuroSigma Receives Global Quality Control Certification
Devices Regulatory
 HSMN NewsFeed - 6 Jun 2012
HemCon Adds Barry Starkman as CEO
Devices Personnel
 HSMN NewsFeed - 29 May 2012
Boston Scientific Announces Expanded Indication For CRE Wireguided Balloon Dilator
Devices Gastroenterology Interventional
 HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
Devices Interventional Neurology Acquisitions
 HSMN NewsFeed - 7 May 2012
Advanced Cardiac Therapeutics Announces Several Key Appointments
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Apr 2012
NeuroSigma Awarded NIH Grant for Further Development of Its Thin-Film Nitinol Covered Neurovascular Stent
Devices Neurology Interventional
 HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
Devices Neurology Personnel
 HSMN NewsFeed - 21 Mar 2012
UCLA Professor of Neurosurgery and NeuroSigma Co-Founder Honored for Groundbreaking Work including Deep Brain Stimulation for Treatment of PTSD
Devices Neurosurgery Personnel
 HSMN NewsFeed - 14 Mar 2012
Paradigm Spine, LLC Announces Strategic Promotions and Hiring of Key Personnel to Ensure Long-Term Growth and Success
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 31 Jan 2012
AngioDynamics to Acquire Navilyst Medical for $372 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2011
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2011
China Nuvo Solar Introduces Management Team for Medical and Surgical Products Acquisition SurgLine
Devices Surgery Personnel Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2011
Dennis M. Flannelly Joins Phadia as Head of U.S. Marketing and Strategy
Diagnostics Personnel
 HSMN NewsFeed - 18 Jul 2011
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Devices Interventional Licensing
 HSMN NewsFeed - 12 Jul 2011
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 25 Apr 2011
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
Devices Neurology
 HSMN NewsFeed - 11 Apr 2011
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Feb 2011
Lilly Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
Roger Hungerford Joins Board of Access Scientific
Devices Personnel
 HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jan 2011
Dyax and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Oct 2010
AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2010
Third Rock Ventures Appoints Steven Paul, M.D., as Venture Partner
Venture Capital Personnel
 HSMN NewsFeed - 18 Aug 2010
Aethon Names Joseph Gentile New Vice President of Sales
Devices Personnel
 HSMN NewsFeed - 5 Aug 2010
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2010
Medtronic Names Caroline Stockdale as Senior Vice President of Human Resources
Devices Personnel
 HSMN NewsFeed - 1 Mar 2010
First Perry Baromedical Sigma Elite Hyperbaric Chamber with EMR Installed at Stillwater Medical Center
Devices Wound Care
 HSMN NewsFeed - 1 Mar 2010
Gentium Announces Management Changes and Corporate Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2009
Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2009
FDA Classifies Previously Announced Medtronic Physician Advisory on Small Subset of Kappa and Sigma Pacemakers as Class I Recall
Devices Cardiology Product Recall
 HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS
 HSMN NewsFeed - 5 May 2009
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
Biopharmaceuticals Urology Licensing Distribution
 HSMN NewsFeed - 28 Apr 2009
MAKO Surgical Corp. Appoints Senior Vice President of Strategic Marketing and Business Development
Devices Orthopaedic Surgery Personnel
 HSMN NewsFeed - 17 Apr 2009
Lilly Names Susan Mahony Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2009
Baxter Enters into Exclusive Distribution Agreement with SIGMA International for Infusion Pumps
Devices Distribution
 HSMN NewsFeed - 17 Mar 2009
Cardinal Health Launches New Products for the Operating Room
Devices Surgery
 HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS
 HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Aug 2008
ATS Medical Appoints New Vice President of Operations
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Jul 2008
BSD Medical's Premier Cancer Treatment System Can Now Treat Children's Cancers
Devices Oncology
 HSMN NewsFeed - 30 Jun 2008
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 20 Jun 2008
Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program
Diagnostics
 HSMN NewsFeed - 14 May 2008
Pfizer Names Garry Nicholson to Head New Oncology Business Unit
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 May 2008
Anesiva Announces Expansion of Zingo Agreement in Europe
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 11 Feb 2008
Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries
Biopharmaceuticals Drug Delivery Distribution Licensing
 HSMN NewsFeed - 11 Feb 2008
SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2008
Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2007
30-Year Johnson & Johnson Veteran Joins ConforMIS' Renowned Executive Team
Devices Orthopaedic Personnel
 HSMN NewsFeed - 17 Oct 2007
Hyperthermia Combined with Radiation and Androgen Therapy Provides Positive Results with Reduced Toxicity for Prostate Cancer Treatments
Devices Oncology
 HSMN NewsFeed - 15 Oct 2007
Positron Corporation Hires VP of Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 8 Oct 2007
AVANIR Granted Special Protocol Assessment (SPA) From FDA for Confirmatory Phase III Trial of Zenvia in Patients With PBA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Sep 2007
Alphatec Holdings, Inc. Names Veteran Operations Executive Kermit P. Stott as Vice President of Operations
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 31 Jul 2007
RegeneRx Biopharmaceuticals, Inc. Updates Clinical Trials Program
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 22 Jun 2007
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jun 2007
AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2007
Spectranetics Appoints Donald Fletcher Vice President of Quality Assurance and Regulatory Compliance
Devices Personnel
 HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2007
Jeffrey Kao Named Senior Vice President of Sales, Clinical and IT Solutions at Hill-Rom
Devices Personnel
 HSMN NewsFeed - 18 Apr 2007
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2007
Bausch & Lomb Names Efrain Rivera Senior Vice President and Chief Financial Officer, Succeeding Stephen C. McCluski Who Will Retire June 30, 2007
Devices Personnel
 HSMN NewsFeed - 14 Mar 2007
AVANIR Pharmaceuticals Appoints New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2007
Angiotech appoints Victor Diaz as Senior Vice President, Global Manufacturing & Supply Chain Management
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 28 Feb 2007
AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Feb 2007
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2007
Optivus Widens Industry Experience with New Vice President of Sales
Devices Oncology Personnel
 HSMN NewsFeed - 1 Feb 2007
Anavex Life Sciences Corp. Outlines Its Central Nervous System (CNS) Portfolio of Novel Therapeutics
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Dec 2006
SciClone and Sigma-Tau Complete Enrollment in Phase 3 Triple Therapy Hepatitis C Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2006
SciClone and Sigma-Tau Announce Positive Interim Survival Data From Large Phase 2 Malignant Melanoma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2006
HealthTronics Announces Appointment of New CFO
Devices Personnel
 HSMN NewsFeed - 11 Dec 2006
Tyco Unveils Senior Management Team to Lead Tyco Healthcare as Independently Traded Company
Devices Personnel
 HSMN NewsFeed - 20 Nov 2006
Alfred Rudolph, M.D. Is Leaving as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2006
Cambrex Announces Sale of Bioproducts and Biopharma Subsidiaries to Lonza for $460 Million In Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Oct 2006
Debiopharm Signs International License Agreements for Sanvar(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Oct 2006
Hydromedix Group, Inc. is Pleased to Announce the Appointment of Dr. Jeffery M. Bishop, D.O. as Vice President and Medical Director
Devices Personnel
 HSMN NewsFeed - 3 Oct 2006
Transport Pharmaceuticals Hires Vice President of Quality Systems and Operational Excellence
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Sep 2006
BSD Medical's System Used in Phase II Trial to Allow Surgical Removal of Previously Inoperable Cancer
Devices Oncology
 HSMN NewsFeed - 21 Jul 2006
Exagen Diagnostics Names Luc Van Hove Vice President, Quality, Regulatory, Medical Affairs and Chief Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 13 Jul 2006
Medtronic Marks Sale of 1 Millionth CapSureFix(R) Novus Model 5076 Cardiac Pacing Lead
Devices Cardiology
 HSMN NewsFeed - 5 Jul 2006
Cardinal Health Aligns Manufacturing Businesses, Names International President
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 25 May 2006
SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2006
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2006
Novavax Strengthens Vaccine Development Team with Two New Appointments
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 70

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 70 additional stories matching:
Sigma
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!